US$ 24.22
retatrutide nejm 2023 obesity trial ly3437943 Research Guide: What the Phase 2 Data Reported (2026) Incretin triple agonist retatrutide (LY3437943)
Description
[DOI] [PubMed] [Google Scholar] 6.Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, et al

Concomitant antidiabetic medication use may also confound the observed neurological event associations

This condition is often called an eye stroke and is caused by restricted blood flow to the optic nerve

Class I recalls are the most serious
